Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on August 15, 2016, to report significant financing activities. The company announced the refinancing of a portion of its existing senior secured term B-4 loan facility through the issuance of a new $1.2 billion senior secured term B-7 loan credit facility maturing in February 2024. Additionally, HCA completed the public offering of $1.2 billion in aggregate principal amount of 4.500% Senior Secured Notes due 2027. The net proceeds from both the term loan and the notes issuance, estimated at approximately $1.186 billion after expenses for the notes, are intended to be used for refinancing existing debt and for general corporate purposes. These transactions demonstrate HCA's proactive approach to managing its capital structure, extending debt maturities, and potentially optimizing its borrowing costs. Investors should note the terms of the new debt, including interest rates, amortization schedules, and potential prepayment premiums, as well as the security and covenants associated with the new notes.
Key Highlights
- 1Refinanced a portion of existing senior secured term B-4 loan facility with a new $1.2 billion senior secured term B-7 loan credit facility maturing February 15, 2024.
- 2Issued $1.2 billion aggregate principal amount of 4.500% Senior Secured Notes due February 15, 2027.
- 3Net proceeds from these transactions will be used to refinance existing debt and for general corporate purposes.
- 4The new Term Loan B-7 facility has an interest rate of LIBOR plus 2.75% or base rate plus 1.75%.
- 5The Senior Secured Notes are guaranteed by the Parent Guarantor on a senior unsecured basis and by certain subsidiaries on a senior secured basis.
- 6The Notes are secured by first-priority liens on certain assets, ranking pari passu with the cash flow credit facility and existing first lien notes, and second-priority liens on certain receivables collateral.
- 7Covenants in the Indenture for the Notes restrict actions such as creating liens, sale and lease-back transactions, and asset sales, subject to certain limitations and potential modification upon achieving investment grade ratings.